Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Crit Care Med. 2016 Jun;44(6):1082–1090. doi: 10.1097/CCM.0000000000001617

Table 2.

Mortality of patients undergoing HSCT and developing ARDS, compared to those who did not develop ARDS.

Time ARDS (n = 133) No ARDS (n = 2505) p
Mortality 28 days 16 (12%) 14 (0.6%) < 0.001
(following transplant) 90 days 48 (36.1%) 57 (2.3%) < 0.001
1 year 89 (66.9%) 295 (11.8%) < 0.001
5 years 101 (75.9%) 754 (30.1%) < 0.001